Bio-Nucleonics Inc entered the industry of Radioactive Diagnostic Substances in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code , which describes it as a Radioactive Diagnostic Substances. For further clarification, the SIC classifies this business under the code and described it as a Radioactive Diagnostic Substances. The business provides service to the B2B market.
To acquire more information, please contact Rosanne Satz by calling No number given during business hours. You can also write to the business’ Headquarters at 8880 Nw 20th St # I, Miami, Florida FL 33172. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Bio-Nucleonics Inc |
| Representative: | Rosanne Satz |
| Place of Business: | 8880 Nw 20th St # I, Miami, FL 33172 |
| Contact Number: | No number given |
| Type of Service: | Radioactive Diagnostic Substances |
| Locality: | Headquarters |
| Market Type: | B2B (Business to Business) |
| Began: | 1994 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Bio-Nucleonics Inc is a company operating from Miami-Dade, Florida providing professional Radioactive Diagnostic Substances and relevant B2B variables. It was founded in 1994 and registered with the SIC code as Radioactive Diagnostic Substances, and with the NAICS code as Radioactive Diagnostic Substances.
With a current employee count of 1 to 4, Bio-Nucleonics Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Rosanne Satz at No number given for related queries, or to locate its Headquarters using the coordinates 25.7918045,-80.34084840.
The Headquarters can also be found at the street address 8880 Nw 20th St # I in Miami, Florida 33172 and can be engaged online through the company website at , the company Twitter , and Facebook page .